Understanding the treatment preferences of seriously ill patients

The New England Journal of Medicine
Terri R FriedHeather Allore

Abstract

The questions patients are asked about their preferences with regard to life-sustaining treatment usually focus on specific interventions, but the outcomes of treatment and their likelihood affect patients' preferences. We administered a questionnaire about treatment preferences to 226 persons who were 60 years of age or older and who had a limited life expectancy due to cancer, congestive heart failure, or chronic obstructive pulmonary disease. The study participants were asked whether they would want to receive a given treatment, first when the outcome was known with certainty and then with different likelihoods of an adverse outcome. The outcome without treatment was specified as death from the underlying disease. The burden of treatment (i.e., the length of the hospital stay, extent of testing, and invasiveness of interventions), the outcome, and the likelihood of the outcome all influenced treatment preferences. For a low-burden treatment with the restoration of current health, 98.7 percent of participants said they would choose to receive the treatment (rather than not receive it and die), but 11.2 percent of these participants would not choose the treatment if it had a high burden. If the outcome was survival but with se...Continue Reading

References

Dec 1, 1992·Journal of the American Geriatrics Society·D R RoyallK F Gray
May 27, 1982·The New England Journal of Medicine·B J McNeilA Tversky
May 1, 1995·Journal of the American Geriatrics Society·G A SachsJ Lynn
Oct 15, 1995·Annals of Internal Medicine·M R Gillick
Jun 1, 1993·Journal of General Internal Medicine·R S SchonwetterB E Robinson
Feb 14, 1996·JAMA : the Journal of the American Medical Association
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M D BrundageW J Mackillop
Mar 1, 1997·Annals of Internal Medicine·L C HansonM Danis
Apr 1, 1997·Journal of the American Geriatrics Society·J Lynn
Oct 6, 1997·Annals of Internal Medicine·D L PatrickR F Uhlmann
Dec 31, 1997·Annals of Internal Medicine·L M SchwartzH G Welch
Apr 29, 1998·JAMA : the Journal of the American Medical Association·S K InouyeJ Concato
Sep 12, 1998·Annals of Internal Medicine·J A TulskyR M Arnold
Feb 18, 1999·JAMA : the Journal of the American Medical Association·J A GazmararianJ P Koplan
Jun 5, 1999·Annals of Internal Medicine·B Lo, L Snyder
Nov 30, 1999·JAMA : the Journal of the American Medical Association·T E Finucane
Nov 14, 2000·JAMA : the Journal of the American Medical Association·R M NavariM Siegler
Nov 14, 2000·JAMA : the Journal of the American Medical Association·K E SteinhauserJ A Tulsky
Jul 17, 2001·Journal of the American Geriatrics Society·E RatnerK McSteen

❮ Previous
Next ❯

Citations

Apr 26, 2006·Archives of Internal Medicine·Terri R FriedJoel A Dubin
Dec 12, 2007·Archives of Internal Medicine·Judith E NelsonR Sean Morrison
Jan 14, 2009·Archives of Internal Medicine·Gulshan SharmaJames S Goodwin
Mar 11, 2009·Archives of Internal Medicine·Amresh HanchateEzekiel Emanuel
Mar 24, 2010·Archives of Internal Medicine·Liana Fraenkel, Terri R Fried
Oct 28, 2010·JAMA : the Journal of the American Medical Association·Theodore J IwashynaKenneth M Langa
Sep 27, 2012·JAMA : the Journal of the American Medical Association·Terri R FriedMichael W Rabow
Oct 7, 2011·Medizinische Klinik, Intensivmedizin und Notfallmedizin·M Wehler
Dec 25, 2010·Der Anaesthesist·H Rüddel, M Zenz
Oct 27, 2006·Intensive Care Medicine·Charles L SprungUNKNOWN ETHICATT Study Group
Aug 24, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Lorenzo RossaroFrederick J Meyers
Jan 16, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Tracy M RobinsonJames A Tulsky
Sep 25, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Vanessa L BeesleyAdele C Green
Mar 21, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Alexandra GamelinEtienne Mullet
Sep 28, 2007·Journal of General Internal Medicine·Joseph V AgostiniJohn Concato
Apr 24, 2009·Journal of General Internal Medicine·Amber E BarnatoElliott S Fisher
Jan 13, 2012·Journal of General Internal Medicine·J Andrew Billings
Jul 10, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José ExpósitoJoana Pons
Jan 30, 2004·The American Journal of Medicine·Mary E Tinetti, Terri Fried
Oct 31, 2003·Journal of the American College of Surgeons·Soumitra R EachempatiJoseph J Fins
Mar 11, 2004·Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing·Linda A BriggsElaine R Colvin
Aug 9, 2003·Obstetrics and Gynecology·C O Granai
Jul 25, 2012·Nature Reviews. Clinical Oncology·Supriya MohileArti Hurria
Oct 17, 2002·Internal Medicine Journal·J Vinen
Dec 1, 2007·Seminars in Interventional Radiology·Toby C Campbell, Jamie H Von Roenn
Apr 5, 2002·The New England Journal of Medicine·Diane E Meier, R Sean Morrison
Aug 16, 2002·The New England Journal of Medicine·Andrew I Batavia, Lauro S Halstead
Jun 18, 2004·The New England Journal of Medicine·R Sean Morrison, Diane E Meier
Oct 16, 2009·The New England Journal of Medicine·Manjula Kurella TamuraCharles E McCulloch
Apr 23, 2004·The New England Journal of Medicine·Bruce P HimelsteinDavid Weissman
Dec 31, 2004·The New England Journal of Medicine·Mary E TinettiJoseph V Agostini
Dec 16, 2005·The New England Journal of Medicine·David CasarettArthur Caplan
Feb 9, 2006·The Journal of Medicine and Philosophy·Tomasz R Okon
Feb 23, 2013·The American Journal of Bioethics : AJOB·Samuel M BrownRobert Paine
Jul 5, 2005·Journal of Palliative Medicine·Jennifer KapoDavid Casarett
Oct 22, 2005·Journal of Palliative Medicine·Nathan E GoldsteinTerri R Fried
Dec 22, 2007·Journal of Palliative Medicine·Allan Garland, Alfred F Connors
May 6, 2008·Journal of Palliative Medicine·Elmer D AbboDavid O Meltzer
Feb 12, 2009·Journal of Palliative Medicine·Muriel R Gillick
Jan 7, 2010·Journal of Palliative Medicine·Susan C StoneChristian D McClung
Nov 26, 2009·Journal of Palliative Medicine·Wendy G Anderson, Nathan E Goldstein
Nov 26, 2009·Journal of Palliative Medicine·James Downar, Laura Hawryluck
Sep 14, 2011·Journal of Palliative Medicine·J Andrew Billings
Jun 14, 2012·Journal of Palliative Medicine·David CasarettJoan M Teno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Diane E Meier, R Sean Morrison
Critical Care Medicine
Christian B LloydGerard A Silvestri
The New England Journal of Medicine
Jeffrey M DrazenPhilip Green
© 2022 Meta ULC. All rights reserved